Natural antioxidants and neurodegenerative diseases

被引:43
作者
Bastianetto, S [1 ]
Quirion, R [1 ]
机构
[1] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2004年 / 9卷
关键词
vitamins; polyphenols; natural extracts; Alzheimer; stroke; brain aging; review;
D O I
10.2741/1493
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD) diseases are defined by a progressive neuronal dysfunction and an ensuing behavioral dysfunction. Although protein aggregation (i.e beta-amyloid and alpha-synuclein) plays a pivotal role in both AD and PD, there is increasing evidence that excessive accumulation of reactive oxygen species (ROS) that occurs during normal and pathological brain aging contributes to neuronal losses and dysfunction. Based on these observations, it has been hypothesized that natural antioxidants derived from food, beverages and natural extracts may be beneficial to prevent or delay the occurrence of age-related cognitive deficits and neurodegenerative diseases. We will summarize in this review the role of oxidative stress in pathological brain aging, and provide evidence for a role for antioxidant molecules as therapeutic agents. We will also focus on the various mechanisms underlying their neuroprotective effects in in vivo and in vitro models of neurotoxicity.
引用
收藏
页码:3447 / 3452
页数:6
相关论文
共 65 条
[41]   Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells [J].
Miloso, M ;
Bertelli, AAE ;
Nicolini, G ;
Tredici, G .
NEUROSCIENCE LETTERS, 1999, 264 (1-3) :141-144
[42]   Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease [J].
Montgomery, SA ;
Thal, LJ ;
Amrein, R .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (02) :61-71
[43]   Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease on a biracial community study [J].
Morris, MC ;
Evans, DA ;
Bienias, JL ;
Tangney, CC ;
Bennett, DA ;
Aggarwal, N ;
Wilson, RS ;
Scherr, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (24) :3230-3237
[44]   Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults - The Cardiovascular Health Study [J].
Mukamal, KJ ;
Longstreth, WT ;
Mittleman, MA ;
Crum, RM ;
Siscovick, DS .
STROKE, 2001, 32 (09) :1939-1945
[45]  
Obisesan TO, 1998, J AM GERIATR SOC, V46, P1
[46]   Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro [J].
Ono, K ;
Hasegawa, K ;
Naiki, H ;
Yamada, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (06) :742-750
[47]   Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro:: implications for the prevention and therapeutics of Alzheimer's disease [J].
Ono, K ;
Yoshiike, Y ;
Takashima, A ;
Hasegawa, K ;
Naiki, H ;
Yamada, M .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (01) :172-181
[48]  
Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185
[49]   Neuroprotection by the metabolic antioxidant alpha-lipoic acid [J].
Packer, L ;
Tritschler, HJ ;
Wessel, K .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (1-2) :359-378
[50]   Potential therapeutic properties of green tea polyphenols in Parkinson's disease [J].
Pan, TH ;
Jankovic, J ;
Le, WD .
DRUGS & AGING, 2003, 20 (10) :711-721